Work

FondaKIDS: A prospective pharmacokinetic and safety study of fondaparinux in children between 1 and 18 years of age

Year: 2011

Type: article

Study design: Clinical Trial

Source: Pediatric Blood & Cancer

DOI: 10.1002/pbc.23011

Authors: Guy Young, Donald L. Yee, Sarah H. O'Brien, Rachna Khanna, April Barbour, Diane J. Nugent

Institutions: University of Southern California, Children's Hospital Los Angeles, Baylor College of Medicine, Texas Children's Hospital, Nationwide Children's Hospital, The Ohio State University, GlaxoSmithKline (United States), Children's Hospital of Orange County

Language: English

Topic: Venous Thromboembolism Diagnosis and Management

Subfield: Internal Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: GlaxoSmithKline, U.S. Food and Drug Administration

Award: G791117619

OpenAlex ID: W2149928546

FWCI: 4.999

Cites: 27

Cited by: 64

Related to: 10